GlassScriptPhysician profile
Alexandra Collins
NPI 1992323612
$10,129.71
in general payments reported to CMS, 2019-2025
43 companies · $2,301 in 2025
The $2,301 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,900 · 2022: $1,007 · 2023: $2,073 · 2024: $848 · 2025: $2,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,049 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,048.60 |
| Education | $173.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,498.45 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,141.81 | 2022-2025 | Dupixent |
| Janssen Biotech, INC. | $887.05 | 2022-2025 | Tremfya |
| Genzyme Corporation | $611.02 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $593.76 | 2022-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $484.05 | 2022-2025 | Odomzo, Blu-U, Ilumya |
| Dermavant Sciences, INC. | $423.51 | 2022-2024 | Vtama |
| Otsuka America Pharmaceutical, INC. | $367.45 | 2021 | |
| Vanda Pharmaceuticals INC. | $335.15 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $274.80 | 2021 | |
| Alkermes, INC. | $260.96 | 2021 | |
| Janssen Pharmaceuticals, INC | $252.19 | 2021 | |
| Lilly USA, LLC | $241.74 | 2022-2025 | Taltz |
| Neurocrine Biosciences, INC. | $240.67 | 2021 | |
| Validus Pharmaceuticals LLC | $239.58 | 2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.